← back to search

Atul J. Butte

UCSF Helen Diller Family Comprehensive Cancer Center · US
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Bioinformatics and Genomic Networks, Gene expression and cancer classification, Cancer Genomics and Diagnostics, and Genomics and Rare Diseases.
h-index
112
citations
67,336
works
775
NIH funding
primary concept
Medicine
email

Recent publications

REACH-BMAS (Body-Map Auto-Segmentation): screening body-map drawings for chronic widespread pain
Pain Medicine 2026cited by 0position: middledoi
Evaluating large language models for drafting emergency department encounter summaries
PLOS Digital Health 2025cited by 19position: middledoi
Perceptual and technical barriers in sharing and formatting metadata accompanying omics studies
Cell Genomics 2025cited by 15position: middledoi
The MI-CLAIM-GEN checklist for generative artificial intelligence in health
Nature Medicine 2025cited by 14position: middledoi
Tumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesis
Nature Communications 2025cited by 5position: middledoi
DeepHeme, a high-performance, generalizable deep ensemble for bone marrow morphometry and hematologic diagnosis
Science Translational Medicine 2025cited by 4position: middledoi
Epistasis regulates genetic control of cardiac hypertrophy
Nature Cardiovascular Research 2025cited by 4position: middledoi
Ethical and regulatory challenges of large language models in medicine
The Lancet Digital Health 2024cited by 256position: middledoi
Use of a Large Language Model to Assess Clinical Acuity of Adults in the Emergency Department
JAMA Network Open 2024cited by 129position: lastdoi
Evaluating large language models as agents in the clinic
npj Digital Medicine 2024cited by 117position: middledoi
Evaluating the use of large language models to provide clinical recommendations in the Emergency Department
Nature Communications 2024cited by 92position: lastdoi
To do no harm — and the most good — with AI in health care
Nature Medicine 2024cited by 69position: middledoi
The Integration of Clinical Trials With the Practice of Medicine
JAMA 2024cited by 64position: middledoi
To Do No Harm — and the Most Good — with AI in Health Care
NEJM AI 2024cited by 57position: middledoi
CORAL: Expert-Curated Oncology Reports to Advance Language Model Inference
NEJM AI 2024cited by 56position: lastdoi
Medical Ethics of Large Language Models in Medicine
NEJM AI 2024cited by 50position: middledoi
A comparative study of large language model-based zero-shot inference and task-specific supervised classification of breast cancer pathology reports
Journal of the American Medical Informatics Association 2024cited by 39position: lastdoi
Single-cell RNA-Seq analysis reveals cell subsets and gene signatures associated with rheumatoid arthritis disease activity
JCI Insight 2024cited by 28position: middledoi
Modernizing the Data Infrastructure for Clinical Research to Meet Evolving Demands for Evidence
JAMA 2024cited by 24position: middledoi
Topic modeling on clinical social work notes for exploring social determinants of health factors
JAMIA Open 2024cited by 23position: lastdoi
Algorithmic Identification of Treatment‐Emergent Adverse Events From Clinical Notes Using Large Language Models: A Pilot Study in Inflammatory Bowel Disease
Clinical Pharmacology & Therapeutics 2024cited by 23position: middledoi
Assessing Large Language Models for Oncology Data Inference From Radiology Reports
JCO Clinical Cancer Informatics 2024cited by 14position: middledoi
Learning epistatic polygenic phenotypes with Boolean interactions
PLoS ONE 2024cited by 4position: middledoi
Assessing the potential of GPT-4 to perpetuate racial and gender biases in health care: a model evaluation study
The Lancet Digital Health 2023cited by 427position: middledoi
The promise of digital healthcare technologies
Frontiers in Public Health 2023cited by 200position: middledoi
AI in Medicine—<i>JAMA</i>’s Focus on Clinical Outcomes, Patient-Centered Care, Quality, and Equity
JAMA 2023cited by 78position: middledoi
A certified de-identification system for all clinical text documents for information extraction at scale
JAMIA Open 2023cited by 47position: lastdoi
Electrocardiogram Detection of Pulmonary Hypertension Using Deep Learning
Journal of Cardiac Failure 2023cited by 38position: middledoi
Serum tryptophan metabolites are associated with erosive hand osteoarthritis and pain: results from the DIGICOD cohort
Osteoarthritis and Cartilage 2023cited by 30position: middledoi
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study
EClinicalMedicine 2023cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marina Sirota · University of California, San Francisco11 papers (2012–2024)Dvir Aran · Technion – Israel Institute of Technology10 papers (2015–2019)Sanchita Bhattacharya · University of California, San Francisco10 papers (2015–2022)Madhumita Sushil · University of California, San Francisco8 papers (2024–2025)Travis Zack · City College of San Francisco8 papers (2023–2025)Brenda Y. Miao · University of California, San Francisco8 papers (2024–2025)Zicheng Hu · Jiangnan University6 papers (2017–2022)Rima Arnaout · Intelligent Health (United Kingdom)6 papers (2020–2025)Christopher Y. K. Williams · University of California, San Francisco5 papers (2024–2025)Euan A. Ashley · Stanford Health Care5 papers (2015–2025)Beau Norgeot · Covance (United States)5 papers (2018–2025)Boris Oskotsky · University of California, San Francisco4 papers (2017–2023)Omer Ronen · University of California System4 papers (2023–2025)Bin Yu · University of California, Berkeley4 papers (2023–2025)Karl Kumbier · University of California, Berkeley4 papers (2023–2025)Merle Behr · University of Regensburg4 papers (2023–2025)Patrick Dunn · University of Birmingham4 papers (2015–2018)Benjamin S. Glicksberg · University of Hong Kong4 papers (2018–2023)Milena Gianfrancesco · Pfizer (United States)3 papers (2019–2025)David Klatzmann · University Hospital Heidelberg3 papers (2022–2024)